DELFI DIAGNOSTICS
Delfi Diagnostics detect cancer early, when it is most curable, using high precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients.
DELFI DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2019-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.delfidiagnostics.com
Total Employee:
101+
Status:
Active
Contact:
410-696-3304
Email Addresses:
[email protected]
Total Funding:
330.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Nginx Sitelinks Search Box
Similar Organizations
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
Juno Diagnostics
Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.
LightDeck Diagnostics
LightDeck is a developer of on-the-spot diagnostic products used to offer fast, accurate, simple, and low-cost diagnostic tests.
Current Advisors List
Current Employees Featured
Founder
Investors List
PTX Capital
PTX Capital investment in Series B - Delfi Diagnostics
Northpond Ventures
Northpond Ventures investment in Series B - Delfi Diagnostics
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Delfi Diagnostics
Brown Advisory
Brown Advisory investment in Series B - Delfi Diagnostics
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Delfi Diagnostics
Foresite Capital
Foresite Capital investment in Series B - Delfi Diagnostics
Point Field Partners
Point Field Partners investment in Series B - Delfi Diagnostics
OrbiMed
OrbiMed investment in Series B - Delfi Diagnostics
Rock Springs Capital
Rock Springs Capital investment in Series B - Delfi Diagnostics
T. Rowe Price
T. Rowe Price investment in Series B - Delfi Diagnostics
Key Employee Changes
Date | New article |
---|---|
2022-07-12 | Jessica Meng Joins Delfi Diagnostics as Chief Commercial Officer |
2021-10-07 | Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer |
Official Site Inspections
http://www.delfidiagnostics.com Semrush global rank: 3.55 M Semrush visits lastest month: 4.11 K
- Host name: ec2-52-38-14-167.us-west-2.compute.amazonaws.com
- IP address: 52.38.14.167
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818